 Suryasarathi Dasgupta, Ph.D.
| Title | Instructor in Microbiology and Immunobiology |
|---|
| Institution | Harvard Medical School |
|---|
| Department | Microbiology and Immunobiology |
|---|
| Address | Harvard Medical School
Micriobiology and Immunob NRB 1058
77 Avenue Louis Pasteur
Boston MA 02115
|
|---|
| Phone | 617/525-0761 |
|---|
|
|
|
 Biography | 2005 -
| Young Investigator travel award at the 14th European Macrophage and Dendritic Cell Conference | | 2006 -
| Travel award for attending the International Dendritic Cell Conference, Edinburgh | | 2007 -
| Young scientist travel grant |
Overview I am a researcher in Biomedicine with an experience of around 10 years in immunology related work. My broad interest is in how cellular immunology and biochemistry can be integrated to understand diagnostic and therapeutic approaches in a better way. I graduated from the Indian Institute of Technology-Bombay, Mumbai, India with a PhD in Biosciences and Bioengineering. I did postdoctoral research in UMRS 872 Equipe 16, INSERM, PARIS, France, wherein I focused to understand the genesis of immune response against therapeutic factor VIII in hemophilia A patients utilizing various model systems. In 2008, I shifted to Boston and worked as an Instructor in Medicine at Channing Laboratory, Brigham and Women's Hospital (2009-2012). From 2012 August onwards, I am working as an Instructor at the Department of Microbiology and Immunobiology, Harvard Medical School. My current work is to understand how components of commensal microflora induce immunomodulation.
I co-authored several peer-reviewed research articles and review articles (35+, 14 as first, co-first or corresponding author) in reputed international journals and presented my work in several international conferences on Immunology, Hematology, Glycobiology and Colitis. My work formed the basis of various projects in our laboratory and resulted in two patents.
I was a member of the European Macrophage and Dendritic cell Society (EMDS, 2005-2007) and currently regular member of AAI (2010 - ) and have been invited to deliver lecture at international conferences and review research and review articles from several journals including Arteriosclerosis, Thrombosis and Vascular Biology & Scientific Reports, Nature Publishing Group.
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Repessé Y, Dasgupta S, Navarrete AM, Delignat S, Kaveri SV, Lacroix-Desmazes S. Mannose-sensitive receptors mediate the uptake of factor VIII therapeutics by human dendritic cells. J Allergy Clin Immunol. 2012 Apr; 129(4):1172-3.
-
Dasgupta S. Mediation of immunoregulation by dendritic cells. ScientificWorldJournal. 2011; 11:118-20.
-
Navarrete AM, Dasgupta S, Teyssandier M, Repesse Y, Delignat S, André S, Bayry J, Kaveri SV, Lacroix-Desmazes S. Endocytic receptor for pro-coagulant factor VIII: relevance to inhibitor formation. Thromb Haemost. 2010 Dec; 104(6):1093-8.
-
Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol. 2010 Oct 1; 185(7):4101-8.
-
Ochoa-Repáraz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 2010 Sep; 3(5):487-95.
-
Dasgupta S, Kasper DL. Novel tools for modulating immune responses in the host-polysaccharides from the capsule of commensal bacteria. Adv Immunol. 2010; 106:61-91.
-
Dimitrov JD, Dasgupta S, Navarrete AM, Delignat S, Repesse Y, Meslier Y, Planchais C, Teyssandier M, Motterlini R, Bayry J, Kaveri SV, Lacroix-Desmazes S. Induction of heme oxygenase-1 in factor VIII-deficient mice reduces the immune response to therapeutic factor VIII. Blood. 2010 Apr 1; 115(13):2682-5.
-
André S, Meslier Y, Dimitrov JD, Repessé Y, Kaveri SV, Lacroix-Desmazes S, Dasgupta S. A cellular viewpoint of anti-FVIII immune response in hemophilia A. Clin Rev Allergy Immunol. 2009 Oct; 37(2):105-13.
-
Navarrete A, Dasgupta S, Delignat S, Caligiuri G, Christophe OD, Bayry J, Nicoletti A, Kaveri SV, Lacroix-Desmazes S. Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A. J Thromb Haemost. 2009 Nov; 7(11):1816-23.
-
Dasgupta S, Bayry J, André S, Dimitrov JD, Kaveri SV, Lacroix-Desmazes S. Auditing protein therapeutics management by professional APCs: toward prevention of immune responses against therapeutic proteins. J Immunol. 2008 Aug 1; 181(3):1609-15.
-
Wootla B, Dasgupta S, Dimitrov JD, Bayry J, Lévesque H, Borg JY, Borel-Derlon A, Rao DN, Friboulet A, Kaveri SV, Lacroix-Desmazes S. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia. J Immunol. 2008 Jun 1; 180(11):7714-20.
-
Lacroix-Desmazes S, Navarrete AM, André S, Bayry J, Kaveri SV, Dasgupta S. Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A. Blood. 2008 Jul 15; 112(2):240-9.
-
Bayry J, Lacroix-Desmazes S, Dasgupta S, Kazatchkine MD, Kaveri SV. Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants? Nat Rev Immunol. 2008 Jan; 8(1):1p following 86; author reply 1p following 86.
-
Lacroix-Desmazes S, Repessé Y, Kaveri SV, Dasgupta S. The role of VWF in the immunogenicity of FVIII. Thromb Res. 2008; 122 Suppl 2:S3-6.
-
Dasgupta S, Navarrete AM, André S, Wootla B, Delignat S, Repessé Y, Bayry J, Nicoletti A, Saenko EL, d'Oiron R, Jacquemin M, Saint-Remy JM, Kaveri SV, Lacroix-Desmazes S. Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation. Haematologica. 2008 Jan; 93(1):83-9.
-
Kaveri SV, Dasgupta S, Andre S, Navarrete AM, Repessé Y, Wootla B, Lacroix-Desmazes S. Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells. Haemophilia. 2007 Dec; 13 Suppl 5:61-4.
-
Delignat S, Dasgupta S, André S, Navarrete AM, Kaveri SV, Bayry J, André MH, Chtourou S, Tellier Z, Lacroix-Desmazes S. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A. Haematologica. 2007 Oct; 92(10):1423-6.
-
Dasgupta S, Bayry J, Lacroix-Desmazes S, Kaveri SV. Human mannose receptor (CD206) in immune response: novel insights into vaccination strategies using a humanized mouse model. Expert Rev Clin Immunol. 2007 Sep; 3(5):677-81.
-
Dasgupta S, Navarrete AM, Bayry J, Delignat S, Wootla B, André S, Christophe O, Nascimbeni M, Jacquemin M, Martinez-Pomares L, Geijtenbeek TB, Moris A, Saint-Remy JM, Kazatchkine MD, Kaveri SV, Lacroix-Desmazes S. A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes. Proc Natl Acad Sci U S A. 2007 May 22; 104(21):8965-70.
-
Dasgupta S, Navarrete AM, Delignat S, Wootla B, Andre S, Nagaraja V, Lacroix-Desmazes S, Kaveri SV. Immune response against therapeutic factor VIII in hemophilia A patients--a survey of probable risk factors. Immunol Lett. 2007 May 15; 110(1):23-8.
-
Dasgupta S, Bayry J, Lacroix-Desmazes S, Kaveri SV. Expert Rev Clin Immunol. Human mannose receptor (CD206) in immune response: novel insights into vaccination strategies using a humanized mouse model. 2007; 3(5):677-681.
-
Dasgupta S, Repessé Y, Bayry J, Navarrete AM, Wootla B, Delignat S, Irinopoulou T, Kamaté C, Saint-Remy JM, Jacquemin M, Lenting PJ, Borel-Derlon A, Kaveri SV, Lacroix-Desmazes S. VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors. Blood. 2007 Jan 15; 109(2):610-2.
-
Lacroix-Desmazes S, Wootla B, Dasgupta S, Delignat S, Bayry J, Reinbolt J, Hoebeke J, Saenko E, Kazatchkine MD, Friboulet A, Christophe O, Nagaraja V, Kaveri SV. Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII. J Immunol. 2006 Jul 15; 177(2):1355-63.
-
Wootla B, Dasgupta S, Mallet V, Kazatchkine MD, Nagaraja V, Friboulet A, Kaveri SV, Lacroix-Desmazes S. Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G. Blood Coagul Fibrinolysis. 2006 Jun; 17(4):229-34.
-
Bayary J, Dasgupta S, Misra N, Ephrem A, Duong Van Huyen JP, Delignat S, Hassan G, Caligiuri G, Nicoletti A, Lacroix-Desmazes S, Kazatchkine MD, Kaveri S. Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms. Int Immunopharmacol. 2006 Apr; 6(4):528-34.
-
Ephrem A, Misra N, Hassan G, Dasgupta S, Delignat S, Duong Van Huyen JP, Chamat S, Prost F, Lacroix-Desmazes S, Kavery SV, Kazatchkine MD. Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin. Clin Exp Med. 2005 Dec; 5(4):135-40.
-
Misra N, Bayary J, Dasgupta S, Ephrem A, Huyen JP, Delignat S, Hassan G, Caligiuri G, Nicoletti A, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Intravenous immunoglobulin and dendritic cells. Clin Rev Allergy Immunol. 2005 Dec; 29(3):201-5.
-
Lacroix-Desmazes S, Wootla B, Delignat S, Dasgupta S, Nagaraja V, Kazatchkine MD, Kaveri SV. Pathophysiology of catalytic antibodies. Immunol Lett. 2006 Feb 28; 103(1):3-7.
-
Bayry J, Misra N, Dasgupta S, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Natural autoantibodies: immune homeostasis and therapeutic intervention. Expert Rev Clin Immunol. 2005 Jul; 1(2):213-22.
-
Misra N, Bayry J, Ephrem A, Dasgupta S, Delignat S, Duong Van Huyen JP, Prost F, Lacroix-Desmazes S, Nicoletti A, Kazatchkine MD, Kaveri SV. Intravenous immunoglobulin in neurological disorders: a mechanistic perspective. J Neurol. 2005 May; 252 Suppl 1:I1-6.
-
Dasgupta S, Chandran V, Bhinge A, Sewlikar S, Nimbkar A, Datta D. Role of L-lysine HCl in adoptive immune therapy towards development of suitable tuberculosis vaccination. Indian J Exp Biol. 2004 Aug; 42(8):758-65.
-
Dasgupta S, Bhinge A, Chandran V, Sewlikar S, Nimbkar A, Datta D. Role of L-lysine HCl in immunopotentiation towards development of suitable tuberculosis vaccination. Vaccine. 2003 Dec 1; 21(32):4722-7.
-
Giri J, Ray A, Dasgupta S, Datta D, Bahadur D. Investigation on Tc tuned nano particles of magnetic oxides for hyperthermia applications. Biomed Mater Eng. 2003; 13(4):387-99.
-
Datta D, Kundu PK, Dasgupta S, Fulzele K, Sewlikar S. Effect of addition of proton carriers in culture medium on growth and secretion of hybridoma cell line OKT3. Indian J Physiol Pharmacol. 2001 Jul; 45(3):367-72.
-
Datta D, Kundu PK, Biswas S, Dasgupta S, Bhinge A, Chandran V. Effect of cationic amino acid, L-lysine and its polymers on the growth and secretion of hybridoma cell line OKT-3. Hybridoma. 2000 Aug; 19(4):339-46.
-
Amar S. Kumbhar, Shirish G. Damle, Suryasarathi T. Dasgupta, Sandhya Y. Rane and Avinash S. Kumbhar. Journal of Chemical Research (S). Nuclease Activity of Oxo-bridged Diiron Complexes. 1999; 98-99.
This graph shows the total number of publications by year.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
|
Dasgupta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|